rs777031588
Variant summary
Our verdict is Likely pathogenic. The variant received 9 ACMG points: 9P and 0B. PP3PP5_Very_Strong
The NM_000255.4(MMUT):c.1084-10A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000198 in 1,613,178 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000255.4 intron
Scores
Clinical Significance
Conservation
Publications
- methylmalonic aciduria due to methylmalonyl-CoA mutase deficiencyInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P
- vitamin B12-unresponsive methylmalonic acidemia type mut-Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- vitamin B12-unresponsive methylmalonic acidemia type mut0Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 9 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| MMUT | ENST00000274813.4 | c.1084-10A>G | intron_variant | Intron 5 of 12 | 1 | NM_000255.4 | ENSP00000274813.3 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152120Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000322 AC: 8AN: 248136 AF XY: 0.0000446 show subpopulations
GnomAD4 exome AF: 0.0000192 AC: 28AN: 1461058Hom.: 0 Cov.: 31 AF XY: 0.0000248 AC XY: 18AN XY: 726854 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152120Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74316 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Pathogenic:3
This sequence change falls in intron 5 of the MUT gene. It does not directly change the encoded amino acid sequence of the MUT protein. This variant is present in population databases (rs777031588, gnomAD 0.02%). This variant has been observed in individual(s) with methylmalonic aciduria (PMID: 23430940; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 203845). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic.
Published functional studies demonstrate c.1084-10 A>G results in activation of a cryptic splice site, supporting a damaging effect (PMID: 27167370, 30041674); In silico analysis supports a deleterious effect on splicing; This variant is associated with the following publications: (PMID: 31622506, 30041674, 27167370, 23430940, 27591164, 34426522, 36717752, 34668645)
Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency Pathogenic:3
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com.
ACMG classification criteria: PS3 supporting, PM2 supporting, PM3 very strong, PP3 supporting
Methylmalonic acidemia Pathogenic:2
Variant summary: MUT c.1084-10A>G alters a non-conserved nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. Several computational tools predict a significant impact on normal splicing: Three predict the variant abolishes/weakens a 3' acceptor site, and four predict it creates a new cryptic intronic 3' acceptor site. Experimental evidence supports these predictions demonstrating that this variant affects mRNA splicing (Forny_2016 and Brasil_2018). The variant allele was found at a frequency of 3.2e-05 in 248136 control chromosomes (gnomAD). c.1084-10A>G has been reported in the literature in the homozygous and compound heterozygous states in multiple individuals affected with Methylmalonic Acidemia (e.g. Liu_2012, Forny_2016, Devi_2017). These data indicate that the variant is very likely to be associated with disease. One publication reports a homozygous patient with less than 10% activity of Methylmalonyl-CoA mutase when compared to reference range (Forny_2016). Five clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as pathogenic (n=4) and likely pathogenic (n=1). Based on the evidence outlined above, the variant was classified as pathogenic.
The c.1084-10A>G variant in MMUT has been reported in 3 compound heterozygote individuals and 1 homozygous individual with methylmalonic aciduria (Liu 2012 PMID: 23430940, Forny 2016 PMID: 27167370, Yu 2021 PMID: 34668645). It has also been identified in 0.02% (1/4828) of South Asian and 0.004% (2/41418) of African chromosomes by gnomAD v. 3 (http://gnomad.broadinstitute.org). This variant has also been reported in ClinVar (Variation ID 203845). Studies have shown that this variant activates a cryptic splice site in intron 5 of the MMUT gene leading to an insertion that would disrupt the protein (Forny 2016 PMID: 27167370, Brasil 2018 PMID: 30041674). In summary, although additional studies are required to fully establish its clinical significance, this variant meets criteria to be classified as likely pathogenic for autosomal recessive methylmalonic acidemia. ACMG/AMP Criteria applied: PM3_S, PS3_M.
Methylmalonic aciduria due to complete methylmalonyl-CoA mutase deficiency Pathogenic:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at